Saint Louis University Menu Search

SLUCare Dermatology Clinical Trials

SLUCare dermatologists are committed to leadership in clinical research programs. As the faculty of Saint Louis University School of Medicine, our staff regularly conducts clinical trials of new medicine and technologies.

Atopic Dermatitis Study for Children 
6 Months - 2 Years Old

SLUCare Dermatology is now seeking patients 6 months to 2 years old who have had a confirmed diagnosis of severe atopic dermatitis within the past 6 months. This is a 4-to 8-week trial of an injectable medication already approved for adults. There is potential to roll over into a long-term extension study.

For more information, call 314-256-3454 or

Uncontrolled Itching Study for Cutaneous T-Cell Lymphoma Patients

SLUCare Dermatology is now seeking patients age 22 and older who have experienced itching from Sézary syndrome or mycosis fungoides — two forms of cutaneous T-cell lymphoma (CTCL). This study will evaluate the effectiveness of a topical medication in providing relief from uncontrolled itching in people with these diseases. Each participant will use either the naloxone lotion during one phase, then switch to a placebo lotion during the second phase, or they will start with the placebo and switch to the naloxone lotion.

For more information, call 314-256-3454 or

Study: Prevention of New Basal Cell Cancer in Gorlin Syndrome Patients

SLUCare Dermatology is seeking study participants, age 18 and older, who've been diagnosed with Gorlin syndrome and have had 10 or more basal cell carcinomas on the face in the past two years. Gorlin syndrome is a rare genetic condition that predisposes patients to developing basal cell carcinoma (BCC). People with Gorlin syndrome can develop hundreds of these cancers over a lifetime, especially on the face and sun-exposed areas.

This clinical trial evaluates the safety and effectiveness of a topical gel in reducing basal cell carcinomas on the face. Half of participants will receive a topical gel with the active ingredient; the other half will receive gel without the active ingredient.

For more information, call 314-256-3454 or

Learn More

 To learn about other current trials, call the research office at 314-256-3454 or email